Back to Authors

Howard, Alan

Mayo Clinic

National Marrow Donor Program

Citations 1

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802

Blood Advances | August 28, 2018 | Volume: 2 | Issue: 15 | Pages: 1882-1888

10.1182/bloodadvances.2018017343 | PMID 30087106

Key PointsHigh-circulating AREG (≥33 pg/mL) reclassifies additional patients into HR categories and further refines the Minnesota aGVHD risk score. Patients with aGVHD and AREG ≥33 pg/mL have lower rates of steroid response, higher NRM, and poorer OS.